Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Haidu Group

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 1
Rounds per year 0.06
Lead investments 0
Key employees Soon

Areas of investment

  • AgTech
  • Health Care
  • Health Diagnostics
  • Biotechnology
Summary

The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Qingsong Fund, Milestone Capital China.

The high activity for fund was in 2019. The typical startup value when the investment from Haidu Group is 10-50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 1 - 5 millions dollars.

Among the various public portfolio startups of the fund, we may underline No-Antibiotics Among the most successful fund investment fields, there is Biotechnology.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Access Technology Partners Connecticut, Shelton, United States
Chameleon Invest Béreldange, Canton Luxembourg, Luxembourg
China Fortune International Trust Beijing, Beijing, China
Cool Japan Fund Chiyoda, Japan
Daintree.VC England, London, United Kingdom
Foresight Ventures Moscow, Moscow, Russia
GCI United States, Waukesha, Wisconsin
Gett England, London, United Kingdom
HaiKe Zhineng -
Innovative Medical Management Anaheim, California, United States
ION Crossover Partners Israel, Tel Aviv, Tel Aviv District
Lakeland Equity Partners -
NKM Capital New York, New York, United States
Qianhai Mengchuang Kongjian China, Guangdong, Shenzhen
Rampart Capital LLP England, London, United Kingdom
Saban Capital Group California, Los Angeles, United States
Symphony Technology Group California, Palo Alto, United States
TinkBig Venture Kuala Lumpur, Malaysia
UFP Fintech England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AgTech
Biotechnology
Health Care
Health Diagnostics
$3M22 May 2019 Shandong

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Haidu Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: